Tempus AI wins FDA clearance for ECG software flagging pulmonary hypertension signs

Reuters2026/08/24 12:31

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Tempus AI won FDA 510(k) clearance for Tempus ECG-PH, an AI tool that flags signs of pulmonary hypertension from standard 12-lead ECGs.
The software targets symptomatic patients aged 40 or older with no known pulmonary hypertension, supporting earlier risk identification in clinical settings.
It is the company’s third FDA-cleared cardiovascular device, expanding its regulated AI product portfolio.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tempus AI Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260824141676) on August 24, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Tempus AI wins FDA clearance for ECG software flagging pulmonary hypertension signs

You may also like

Crypto prices